Back
Preformed Line Products Vs. Novartis AG Industry Stock Comparison
Sell
49
PLPC
Preformed Line Products
Last Price:
$141.52
Seasonality Move:
4.63%
Sell
47
NVSEF
Novartis AG
Last Price:
$107.20
Seasonality Move:
5.97%
Sell
49
Preformed Line Products (PLPC)
is a Sell
Is Preformed Line Products a Buy, Sell or Hold?
-
The current Preformed Line Products [PLPC] share price is $142.72. The Score for PLPC is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
PLPC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Novartis AG (NVSEF)
is a Sell
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $107.20. The Score for NVSEF is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
NVSEF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PLPC Stock Price Chart
What is Preformed Line Products's stock price today?
-
The Preformed Line Products share price today is $142.72The current trend is moderately bullish and PLPC is experiencing slight selling pressure.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $107.20Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVSEF is experiencing selling pressure, which indicates risk of future bearish movement.
PLPC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.17 | Buy |
Relative Strength Index (14 RSI): | 54.51 | Buy |
Chaikin Money Flow: | -7504 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (125.41 - 146.91) | Buy |
Bollinger Bands (100): | (126.45 - 143.07) | Buy |
NVSEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.52 | Buy |
Relative Strength Index (14 RSI): | 45.11 | Sell |
Chaikin Money Flow: | -708751 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (107.53 - 115.13) | Sell |
Bollinger Bands (100): | (98.39 - 109.73) | Buy |
PLPC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 146.26 | Sell |
20-day SMA: | 136.57 | Buy |
50-day SMA: | 137.63 | Buy |
200-day SMA: | 128.84 | Buy |
8-day EMA: | 144.27 | Sell |
20-day EMA: | 140.76 | Buy |
50-day EMA: | 137.43 | Buy |
200-day EMA: | 131.87 | Buy |
NVSEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 110.82 | Sell |
20-day SMA: | 111.72 | Sell |
50-day SMA: | 107.39 | Sell |
200-day SMA: | 107.05 | Buy |
8-day EMA: | 110.22 | Sell |
20-day EMA: | 110.51 | Sell |
50-day EMA: | 108.22 | Sell |
200-day EMA: | 105.09 | Buy |
Preformed Line Products Earnings Growth & PLPC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Preformed Line Products Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novartis AG Technical Analysis
Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |